NCT03656133View on ClinicalTrials.gov

Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

September 26, 2018

Primary Completion Date

March 14, 2022

Study Completion Date

March 26, 2024

Conditions
Oropharyngeal Cancer
Interventions
RADIATION

Radiotherapy fractionation

Standard fractionation at 2Gy once daily or Hyperfractionation at 1.2 Gy twice daily (≥ 6 hours apart)

Trial Locations (1)

33612

H Lee Moffitt Cancer Center and Research Institute, Tampa

All Listed Sponsors
lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT03656133 - Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers | Biotech Hunter | Biotech Hunter